- Live market news
- Stocks
- GUTS
Fractyl Health, Inc. Common Stock
GUTSStockUSA
About
Fractyl Health, Inc. Common Stock
Fractyl Health is a Burlington, Massachusetts-based healthcare company focused on metabolic diseases like obesity and type 2 diabetes. The company developed Revita, an outpatient endoscopic procedure to modify duodenal dysfunction, and Rejuva, a gene therapy platform in preclinical development to enable the pancreas to produce glucagon-like peptide-1 (GLP-1).
Latest news on GUTSranked by Oyticker for market impact
SEC filings
All its filingsWhat GUTS filed
- 6 Nov 2026
- 22 Oct 2026
Restructuring costs · Other event
- 16 Oct 2026
Other event
- 1 Oct 2026
- 24 Sept 2026
- 11 Sept 2026
- 24 Aug 2026
- 10 Aug 2026
- 10 Aug 2026
- 15 Jul 2026
Other event
- 11 Jun 2026
- 4 Jun 2026
Other event
- 12 May 2026
- 12 May 2026
- 11 May 2026
From SEC EDGAR, the public record of what US-listed companies file. Each document opens on sec.gov.
Oyticker provides market information and analysis for educational purposes. It is not investment advice: you remain responsible for your own decisions.